Blog - Page 3212 of 5757

TuesdaySep 11, 2012 9:21 am

Duma Energy Corp. (DUMA) and Hydrocarb Energy Corp. Form Alliance to Explore for World Class Reserves in Africa Oil Concession

Hydrocarb Energy just announced the completion of a farm-out agreement to Duma Energy Corporation. Houston-based Duma, with current production in the Gulf Coast, indirectly owns a 39% working interest in Owambo blocks 1714A, 1715, 1814A, and 1815A in northern Namibia. "Our vast and underexplored concession shows tremendous potential based on the data available to date,” stated Kent Watts, Hydrocarb's Chief Executive. “We have reviewed a third party report already estimating over a billion barrels of un-risked resource potential out of a single identified structure. The Duma partnership allows us to move aggressively towards our ultimate goal, to make a major…

TuesdaySep 11, 2012 8:46 am

TNI BioTech, Inc. (TNIB) Enters Memorandum of Agreement to Open Pharmaceutical Plant

Today before the opening bell, TNI BioTech, a biotech company focused on combating fatal diseases through the activation and mobilization of the body’s immune system, reported that a Memorandum of Agreement has been signed involving the company and MOV-FAS S.A. to open a pharmaceutical plant in Managua, Nicaragua. TNIB has acquired a portfolio patents involving Low-Dose Naltrexone (LDN) for the treatment of HIV/AIDS, cancer and other diseases. This acquisition includes more than two decades of data showing Low Dose Naltraxone (LDN) as an effective immune system modulator, without significant toxic side effects or addicting properties, and can be administered by…

TuesdaySep 11, 2012 8:20 am

KSW, Inc. (KSW) and Related Companies Enter Merger Agreement

Yesterday, KSW, a leading HVAC provider, and Related Companies, a prominent diversified real estate firm, announced that they have entered into a definitive merger agreement. According to the agreement, a subsidiary of Related Companies (“Merger Sub”), will acquire all of the outstanding shares of common stock of KSW for $5.00 per share through a cash tender offer followed by a merger. Valued at approximately $32.1 million, KSW’s Board of Directors unanimously approved of the agreement. Under the terms of the merger agreement, Merger Sub will commence a tender offer for all of the outstanding shares of KSW before September 21,…

MondaySep 10, 2012 5:11 pm

Compugen Ltd. (CGEN) Shows Promise in Fighting Autoimmune Disease

Autoimmunity is defined as an organ’s failure to recognize itself that leads to an immune response against the organ’s cells and tissues. In essence, it’s when a disease causes the body to attack itself. “Regulatory” cells, human cells that control the immune response, called “iTregs,” fail to work properly, and the body’s immune response attacks the body itself as well as the disease. Compugen Ltd., founded in 1993 and headquartered in Tel Aviv Israel, is a company focused on the development of drugs and other products for use against cancer and to assist with problems in the human body’s immune…

MondaySep 10, 2012 3:23 pm

Bio-AMD, Inc. (BIAD) Issues Update on Hopeful Licensing for Commercialization-Ready Technologies

Bio-AMD is a development-stage company operating through its majority-owned UK subsidiaries: WDX Organisation Ltd., a global currency data reference company; and Bio AMD Ltd., a technology developer for medical diagnostic devices. In an update earlier today, BIAD announced that it is in informal discussions with potential partners regarding the commercialization of Bio AMD Ltd.’s hand-held Digital Strip Reader (DSR) and blood coagulation monitor (COAG) technologies. BIAD has readied both DSR and COAG for commercial development in conjunction with a partner, and this morning said that it is in “high level informal talks with suitable prospective partners for both these technologies.”…

MondaySep 10, 2012 2:16 pm

Loans4Less.com, Inc. (LFLS) is “One to Watch”

Loans4Less.com is an online mortgage broker which matches qualified individuals seeking mortgage loans with suitable lenders who offer the company a competitive wholesale lending program. Maintaining an A+ TrustLink rating with the Better Business Bureau, the company provides competitive rates, terms, costs, daily updates, extensive market information, and trusted first-class service to the public. Leveraging its portfolio of 62 different web domains, Loans4Less.com is focused on developing a national consumer platform for conforming residential mortgage programs and implementation of other consumer loan programs via operating providers. The company's expansion strategy includes rapidly growing revenues through strategic and cost-effective advertising, licensing,…

MondaySep 10, 2012 2:06 pm

Skinny Nutritional Corp. (SKNY) Latest Product Supports Increasingly Popular Alkaline Diets

Skinny Nutritional now offers Skinny Water pH+, a high alkaline and electrolyte water, that gives consumers a healthy alternative to acidic beverages such as soft drinks. Michael Salaman, CEO of SKNY, stated, "The body is in an alkaline state when it reaches 7 on a pH scale of 1 to 10. Our bodies tend to be more acidic due to the acidic nature of the typical American diet that consists of soft drinks and processed foods. Skinny Water pH+ targets a pH level of 8 to 9 to help keep the body in balance." The idea for Skinny Water pH+…

MondaySep 10, 2012 1:57 pm

BioLineRX Ltd. (BLRX) Reveals Preclinical Results Demonstrating Safety of Oral Treatment for Celiac Disease

BioLineRx is a biopharmaceutical development company building a portfolio of products for either unmet medical needs or to replace currently available therapies with significant advantages. The company currently has six clinical stage candidates along with nine products in various preclinical development stages for a number of indications. The company announced today that its orally available treatment for celiac disease, BL-7010, was found to be safe and well-tolerated and did not cause any adverse effects (even at high doses) in preclinical studies conducted to date. Additional studies showed that BL-7010 is specific to gliadins, the immunogenic peptides present in gluten that…

MondaySep 10, 2012 1:31 pm

Chimera Energy Corp. (CHMR) Takes in PEMEX Data, Readies for Non-Hydraulic Extraction Roll Out at Mexico’s Largest Hydrocarbon Basin

Chimera Energy reported today that the massive Mexican state-owned Petroleos Mexicanos (PEMEX), the second largest (by market value) non-publicly listed company on earth, recently turned in the well data and logging reports in Poza Rica in order to aide deployment of the company's revolutionary exothermic non-hydraulic extraction method (zero water fracking). Given the undisputed leadership of PEMEX in Latin America's hydrocarbon sector and the rich, sizeable shale oil concentrations throughout the region, this tight-knit relationship with CHMR (as per last month's Memorandum of understanding between CHMR and PEMEX) puts the company in a prime position to roll out their revolutionary…

MondaySep 10, 2012 1:16 pm

Senesco Technologies, Inc. (SNT) Reports Combining SNS01-T with Bortezomib Substantially Increases Effectiveness in Model of Multiple Myeloma

Senesco Technologies announced that the combination of bortezomib – the active component of VELCADE marketed by Millenium: The Takeda Oncology Company – and SNS01-T, which is the subject of Senesco’s ongoing multiple myeloma clinical study, results in substantially better performance in mouse xenograft models than either treatment by itself. SNS01-T enhances bortezomib’s ability to inhibit tumor growth in the mouse model and could potentially be a means of lowering the dose and reducing the severity of treatment-related side effects of bortezomib. As treatment increasingly involves combination therapy, it is important for SNS01-T to work well when added to current multiple…

Site Search

Company Search